Sign in

    Justin Keywood • Stifel

    Justin Keywood's questions to ATS Corp (ATS) leadership

    Justin Keywood's questions to ATS Corp (ATS) leadership • Q1 2026

    Question

    Justin Keywood questioned whether increased U.S. CapEx announcements from life sciences customers are driving activity for ATS, and sought details on the EV settlement cash flow, its tax implications, and the timeline for deleveraging.

    Answer

    CEO Andrew Hider explained that while onshoring trends are favorable for automation, they are not yet a primary driver of current orders. CFO Ryan McLeod confirmed the EV settlement was fully received in the quarter with no immediate tax impact on the cash inflow. He stated the company expects to reach its target leverage range of 2-3x within the current fiscal year, driven by profitability and working capital improvements.

    Ask Fintool Equity Research AI

    Justin Keywood's questions to ATS Corp (ATS) leadership • Q3 2025

    Question

    Justin Keywood from Stifel Financial Corp. asked about the timeline for gross margin expansion to impact operating margins, the drivers behind the significant growth in the Energy/Nuclear segment, and the status of the disputed assets with a large EV customer.

    Answer

    Ryan McLeod, Chief Financial Officer, explained that while modest sequential margin improvement is expected in Q4, more significant benefits will materialize in fiscal 2026 as new transportation business ramps up. Andrew Hider, Chief Executive Officer, and Ryan McLeod added that the nuclear segment's strong bookings were driven by multiple customers across refurbishment, new builds (including SMRs), and fuel fabrication. Regarding the EV dispute, Ryan McLeod clarified that the equipment has been delivered and is in production at the customer's site.

    Ask Fintool Equity Research AI

    Justin Keywood's questions to Healwell Al Inc (HWAIF) leadership

    Justin Keywood's questions to Healwell Al Inc (HWAIF) leadership • Q4 2024

    Question

    Justin Keywood inquired about the impact of the current macro environment and tariff uncertainty on customer discussions, asked if the 'Buy Canadian' opportunity could be quantified, and questioned the expected pace of M&A in 2025.

    Answer

    CEO Dr. Alexander Dobranowski responded that the macro environment has had no negative impact and that the 'Buy Canadian' sentiment is viewed as a material tailwind, though it's too early to quantify precisely. He confirmed that the M&A pipeline remains active and the company will continue to pursue strategically and financially accretive deals.

    Ask Fintool Equity Research AI

    Justin Keywood's questions to Healwell Al Inc (HWAIF) leadership • Q3 2024

    Question

    Justin Keywood sought to quantify the potential revenue impact from the five new Master Service Agreements (MSAs) signed in the quarter and asked for the dollar value of in-the-money warrants that could be exercised.

    Answer

    CEO Alexander Dobranowski did not provide a specific revenue number for the new MSAs but reiterated the company's 'land-and-expand' strategy to grow relationships with these partners over time. CFO Anthony Lam stated that if all in-the-money warrants were exercised, it would add approximately $24 million in cash, bringing the total cash balance to $39 million.

    Ask Fintool Equity Research AI